Establish the exact preparation
Ask for the active ingredient, concentration, base, application area and intended amount. Estriol and estradiol are different hormones, and a facial preparation should not be substituted for another prescribed route or product.
The current Time Out page supplies headline strengths. Other services may require consultation to establish the complete prescription. That is a reason to obtain details, not to borrow a formula from another patient.[source]
Understand the difference between rationale and approval
An older study compared two topical-estrogen preparations over six months in 59 women. It provides research context without proving the performance of every modern blend.[source]
FDA states that there are no approved estriol drugs and does not accept that compounded bioidentical preparations are inherently safer. Terms such as natural or topical should not be used to bypass a discussion of exposure and medical history.[source]
Agree on monitoring before the first shipment
Discuss other hormone therapy, relevant diagnoses and any history requiring estrogen-related caution. Ask which new symptoms require contacting the prescriber and how to reach that person after delivery.
Also clarify the purpose: a facial-skin product is not an established replacement for care of broader menopausal symptoms. The comparison can make ingredients, published claims and costs visible, but the decision to prescribe and the monitoring plan remain individual clinical work.
Sources & further reading
Provider pages establish what a brand markets. Clinical and regulatory sources establish the limits of the evidence. Accessed October 8, 2026.
- CoreAge Rx: Time OutOfficial source; checked October 8, 2026
- Schmidt et al.: topical estrogens and skin aging1996 study of 59 women comparing two estrogen preparations over six months
- FDA: menopause and hormone questionsNo FDA-approved estriol drugs; compounded does not establish superior safety